Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Steven S Zhang"'
Autor:
Baoxia Dong, Steven S Zhang, Wen Gao, Haichun Su, Jun Chen, Fuzi Jin, Ajay Bhargava, Xiequn Chen, Lars Jorgensen, Arthur S Alberts, Jinyi Zhang, Katherine A Siminovitch
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80500 (2013)
The mammalian diaphanous-related formin (mDia1), a Rho-regulated cytoskeletal modulator, has been shown to promote T lymphocyte chemotaxis and interaction with antigen presenting cells, but the mechanisms underpinning mDia1 roles in these processes h
Externí odkaz:
https://doaj.org/article/967355682b9a4efcb48f8d85242c6be5
Autor:
Gang Xie, Robert Spiera, Tabitha N. Kung, Christopher I. Amos, Gary S. Hoffman, John H. Stone, Emily Y. Lu, Paul I.W. de Bakker, Soumya Raychaudhuri, Keisha Carrington, Peter A. Merkel, Steven R. Ytterberg, Nader Khalidi, Steven S. Zhang, Lindsay A. Farrer, Sara L. Pulit, Carol A. Langford, E. William St. Clair, Stephan Ripke, Delnaz Roshandel, Richard Sherva, Alfred Mahr, Simon Carette, Paul F. Dellaripa, Paul A. Monach, Katherine A. Siminovitch, Ulrich Specks, Jeffrey C. Edberg, Philip Seo
Publikováno v:
Arthritis & Rheumatism. 65:2457-2468
Objective To identify genetic determinants of granulomatosis with polyangiitis (Wegener's) (GPA). Methods We carried out a genome-wide association study (GWAS) of 492 GPA cases and 1,506 healthy controls (white subjects of European descent), followed
Autor:
Lars Jorgensen, Katherine A. Siminovitch, Ajay Bhargava, Fuzi Jin, Jinyi Zhang, Arthur S. Alberts, Wen Gao, Steven S. Zhang, Baoxia Dong, Xiequn Chen, Haichun Su, Jun Chen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 11, p e80500 (2013)
PLoS ONE, Vol 8, Iss 11, p e80500 (2013)
The mammalian diaphanous-related formin (mDia1), a Rho-regulated cytoskeletal modulator, has been shown to promote T lymphocyte chemotaxis and interaction with antigen presenting cells, but the mechanisms underpinning mDia1 roles in these processes h
Autor:
Chen H; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Shah A; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Kato S; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Griffin R; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Zhang S; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Pusalkar S; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Cohen L; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Li Y; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Chowdhury SK; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.)., Zhu SX; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.) xiaochun.zhu@takeda.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Sep 16; Vol. 52 (10), pp. 1115-1123. Date of Electronic Publication: 2024 Sep 16.
Autor:
Zhang S; Dicerna Pharmaceuticals, Inc. a Novo Nordisk company, Lexington, Massachusetts, USA., Amrite A; Pyxis Oncology, Boston, Massachusetts, USA., Tan B; BioNTech US Inc., Cambridge, Massachusetts, USA., Jamsen K; Parexel International, Brisbane, Queensland, USA., Pradhan S; Parexel International, Brisbane, Queensland, USA., Choy S; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA., Plotkin H; Dicerna Pharmaceuticals, Inc. a Novo Nordisk company, Lexington, Massachusetts, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Aug 07. Date of Electronic Publication: 2024 Aug 07.
Autor:
Hanley MJ; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc, Lexington, MA, USA. Michael.Hanley@takeda.com., Zhang S; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc, Lexington, MA, USA., Griffin R; Global DMPK, Takeda Development Center Americas, Inc, Lexington, MA, USA., Zhu SX; Global DMPK, Takeda Development Center Americas, Inc, Lexington, MA, USA., Fram RJ; Clinical Science, Takeda Development Center Americas, Inc, Lexington, MA, USA., Lin J; Statistical & Quantitative Sciences, Takeda Development Center Americas, Inc, Lexington, MA, USA., Venkatakrishnan K; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA., Gupta N; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc, Lexington, MA, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2024 Aug; Vol. 42 (4), pp. 343-352. Date of Electronic Publication: 2024 May 24.
Autor:
Linna NB; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zhang S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Farooqi AS; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Jia L; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Huffman W; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Casper DS; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Khalsa AS; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Global spine journal [Global Spine J] 2024 Jun; Vol. 14 (5), pp. 1472-1476. Date of Electronic Publication: 2022 Nov 29.
Autor:
Amrite A; Dicerna Pharmaceuticals Inc., a Novo Nordisk Company, Lexington, MA, USA., Fuentes E; Clinical Pharmacology of Miami, Miami, FL, USA., Marbury TC; Orlando Clinical Research, Orlando, FL, USA., Zhang S; Dicerna Pharmaceuticals Inc., a Novo Nordisk Company, Lexington, MA, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Dec; Vol. 12 (12), pp. 1164-1177. Date of Electronic Publication: 2023 Aug 21.
Autor:
Trinh VQ; University of Adelaide, Adelaide, South Australia 5005, Australia., Zhang S; University of Adelaide, Adelaide, South Australia 5005, Australia., Kovoor J; University of Adelaide, Adelaide, South Australia 5005, Australia.; Queen Elizabeth Hospital, Adelaide, South Australia 5011, Australia., Gupta A; University of Adelaide, Adelaide, South Australia 5005, Australia.; Gold Coast University Hospital, Gold Coast, Queensland 4215, Australia., Chan WO; Queen Elizabeth Hospital, Adelaide, South Australia 5011, Australia.; Discipline of Ophthalmology and Visual Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia.; Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia., Gilbert T; University of Adelaide, Adelaide, South Australia 5005, Australia.; Northern Adelaide Local Health Network, Adelaide, South Australia 5112, Australia., Bacchi S; Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia.; Flinders University, Adelaide, South Australia 5042, Australia.
Publikováno v:
International journal for quality in health care : journal of the International Society for Quality in Health Care [Int J Qual Health Care] 2023 Oct 17; Vol. 35 (4).
Autor:
Lee SH; ZS Associates, Toronto, Canada. frankshinhaw.lee@zs.com., Ojo AT; ZS Associates, Toronto, Canada., Halat M; ZS Associates, Toronto, Canada., Bleibdrey N; ZS Associates, Toronto, Canada., Zhang S; ZS Associates, Toronto, Canada., Chalmers R; ZS Associates, Toronto, Canada., Zimskind D; ZS Associates, Toronto, Canada.
Publikováno v:
International journal of health economics and management [Int J Health Econ Manag] 2023 Sep; Vol. 23 (3), pp. 345-360. Date of Electronic Publication: 2023 Apr 02.